mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 28 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 61.5% | ‑5.2 / 21.5 | 26 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 4,558,321 | 0 | T | G | 59.3% | 15.8 / 29.2 | 27 | T6P (ACC→CCC) | mdtM | multidrug efflux MFS transporter MdtM |
| * | NZ_CP009273 | 1,698,302 | 0 | A | C | 58.3% | 7.2 / 11.3 | 13 | G88G (GGT→GGG) | ydgJ | oxidoreductase |
| * | NZ_CP009273 | 349,999 | 0 | T | G | 57.7% | 10.1 / 29.6 | 26 | V528G (GTG→GGG) | prpE | propionate‑‑CoA ligase |
| * | NZ_CP009273 | 3,531,801 | 0 | C | G | 57.1% | 15.4 / 27.6 | 21 | A353G (GCG→GGG) | yhgF | Tex family protein |
| * | NZ_CP009273 | 4,612,067 | 0 | A | G | 56.5% | 8.4 / 24.2 | 23 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
| * | NZ_CP009273 | 822,955 | 0 | T | G | 56.2% | 10.0 / 17.4 | 16 | T495P (ACC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 3,964,452 | 0 | T | G | 55.0% | 16.6 / 21.6 | 20 | G320G (GGT→GGG) | wecB | UDP‑N‑acetylglucosamine 2‑epimerase (non‑hydrolyzing) |
| * | NZ_CP009273 | 976,689 | 0 | A | G | 54.5% | 4.7 / 11.1 | 11 | I63V (ATC→GTC) | ldtD | L,D‑transpeptidase |
| * | NZ_CP009273 | 3,020,300 | 0 | A | C | 54.5% | 3.0 / 11.0 | 11 | E391D (GAA→GAC) | guaD | guanine deaminase |
| * | NZ_CP009273 | 807,177 | 0 | T | G | 53.8% | 7.7 / 13.0 | 13 | V67G (GTG→GGG) | bioC | malonyl‑ACP O‑methyltransferase BioC |
| * | NZ_CP009273 | 3,924,078 | 0 | T | G | 53.8% | 6.5 / 11.7 | 13 | T126P (ACC→CCC) | ravA | ATPase RavA |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 53.8% | 4.0 / 26.7 | 26 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 209,035 | 0 | T | G | 53.3% | 8.9 / 16.5 | 15 | V73G (GTG→GGG) | tilS | tRNA lysidine(34) synthetase TilS |
| * | NZ_CP009273 | 2,360,810 | 0 | A | G | 53.3% | 8.4 / 14.5 | 15 | G87G (GGA→GGG) | arnC | undecaprenyl‑phosphate 4‑deoxy‑4‑formamido‑L‑arabinose transferase |
| * | NZ_CP009273 | 4,213,521 | 0 | T | G | 53.3% | 12.5 / 18.6 | 15 | K12N (AAA→AAC) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
| * | NZ_CP009273 | 4,213,525 | 0 | C | T | 53.3% | 1.0 / 15.0 | 15 | R11K (AGA→AAA) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
| * | NZ_CP009273 | 262,073 | 0 | A | G | 52.9% | 14.5 / 22.4 | 17 | G64G (GGT→GGC) | BW25113_RS25425 | hypothetical protein |
| * | NZ_CP009273 | 262,051 | 0 | T | G | 52.6% | 17.3 / 22.7 | 19 | T72P (ACC→CCC) | BW25113_RS25425 | hypothetical protein |
| * | NZ_CP009273 | 822,963 | 0 | T | G | 52.6% | 14.1 / 24.8 | 19 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |